Kevin R. Lind

2020 - Longboard Pharmaceuticals

In 2020, Kevin R. Lind earned a total compensation of $2.3M as President and Chief Executive Officer at Longboard Pharmaceuticals.

Compensation breakdown

Bonus$165,506
Option Awards$692,608
Salary$332,090
Stock Awards$1,087,164
Other$9,323
Total$2,286,691

Lind received $1.1M in stock awards, accounting for 48% of the total pay in 2020.

Lind also received $165.5K in bonus, $692.6K in option awards, $332.1K in salary and $9.3K in other compensation.

Rankings

In 2020, Kevin R. Lind's compensation ranked 4,935th out of 13,090 executives tracked by ExecPay. In other words, Lind earned more than 62.3% of executives.

ClassificationRankingPercentile
All
4,935
out of 13,090
62nd
Division
Manufacturing
2,006
out of 5,618
64th
Major group
Chemicals And Allied Products
797
out of 2,251
65th
Industry group
Drugs
688
out of 1,951
65th
Industry
Pharmaceutical Preparations
516
out of 1,456
65th
Source: SEC filing on April 13, 2022.

Lind's colleagues

We found one more compensation record of an executive who worked with Kevin R. Lind at Longboard Pharmaceuticals in 2020.

2020

Philip Perera

Longboard Pharmaceuticals

Chief Medical Officer

News

You may also like